94
Views
8
CrossRef citations to date
0
Altmetric
Theme: Head & Neck Cancer - Review

Synoptic pathology reporting for thyroid cancer: a review and institutional experience

, , , , &
Pages 1073-1079 | Published online: 10 Jan 2014

References

  • Srigley JR, McGowan T, Maclean A et al. Standardized synoptic cancer pathology reporting: a population-based approach. J. Surg. Oncol. 99, 517–524 (2009).
  • Zarbo RJ. Interinstitutional assessment of colorectal carcinoma surgical pathology report adequacy. A College of American Pathologists Q-Probes study of practice pattterns from 532 laboratories and 15,940 reports. Arch. Pathol. Lab. Med. 116(11), 1113–1119 (1992).
  • Leslie KO, Rosai J. Standardization of the surgical pathology report: formats, templates, and synoptic reports. Semin. Diagn. Pathol. 11(4), 253–257 (1994).
  • Kang HP, Devine LJ, Piccoli AL et al. Usefulness of a synoptic data tool for reporting of head and neck neoplasms based on the College of American pathologists cancer checklists. Am. J. Clin. Pathol. 132, 521–530 (2009).
  • Yujer WK, Matthews TW, Dort JC. Making the most of your pathology: standardized histopathology reporting in head and neck cancer. J. Otolaryngol. Head Neck Surg. 37, 48–55 (2008).
  • Tsan CJL, Serpell JW, Poh YY. The impact of synoptic cytology reporting on fine-needle aspiration cytology of thyroid nodules. ANZ J. Surg. 7, 991–995 (2007).
  • Chan NG, Duggal A, Weir MM, Driman DK. Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department. J. Can. Chur. 51(4), 284–288 (2008).
  • Gill AJ, Johns AL, Eckstein R et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 41(2), 161–167 (2009).
  • Karim RZ, van den Berg KS, Colman MH et al. The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 52, 130–138 (2008).
  • Winn RD, Robinson DR, Farmer KC, Bell SW. Deficiencies in pathological reporting of colorectal cancer in victoria. ANZ J. Surg. 78, 796–799 (2008).
  • Chapuis PH, Chan C, Lin BPC et al. Pathology reporting of resected colorectal cancer in New South Wales in 2000. ANZ J. Surg. 77, 963–969 (2007).
  • Keating J, Lolohea S, Kenwright D. Pathology reporting of rectal cancer: a national audit. New Zeal. Med. J. 116, 1–7 (2003).
  • Yunker WK, Matthews TW, Dort JC. Making the most of your pathology:standardized histopathology reporting in head and neck cancer. J. Otolaryngol. Head Neck Surg. 37(1), 48–55 (2008).
  • Kahn C, Simonella L, Sywak M, Boyags S, Ung O, O’Connell D. Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid 22(6), 604–610 (2012).
  • Cooper DS, Doherty GM, Haugen BR et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1–48 (2009).
  • Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer 7(3), 229–239 (2000).
  • Hay ID, Bergstralh EJ, Goellner JR et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114(6), 1057–1058 (1993).
  • Hadjieva T. Scoring patients' risk in differentiated thyroid cancer. Onkologie 24, 561–568 (2001).
  • Brierley JD, Panzarella T, Tsang RW et al. Comparison of different staging systems predictability of patient outcome. Cancer 79(12), 2414–2423 (1997).
  • Hay J. Thyroid cancer algorithm. BC Cancer Agency (2008).
  • Orlov S, Orlov D, Shaytzag M et al. Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma. Head Neck 31, 782–788 (2009).
  • Gillil and FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. Cancer 79(3), 564–573 (1997).
  • Compton CC. Surgical pathology for the oncology patient in the age of standardization: of margins, micrometastasis, and molecular markers. Semin. Radiat. Oncol. 13(4), 382–388 (2003).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.